Archive2-Phenylcyclopropylamine and its derivatives are important chiral pharmaceutical intermediates for antineoplastics, antidepressants and anticoagulants. The strategies for the synthesis of 2-phenylcyclopropylamine mainly include direct synthesis from cyclopropane-based derivatives and de novo construction of cyclopropane(Corey-Chaykovsky reaction, Kulinkovich-de Meijere reaction, etc.). In this paper, synthetic routes of 2-phenylcyclopropylamine derivatives are systematically summarized and outlined, the advantages and disadvantages of each route are briefly reviewed.
Modulating protein function via targeting the allosteric binding sites is an essential strategy for small-molecule drug development. Allosteric modulators show higher selectivity and lower off-target toxicity than orthosteric modulators, and thus have the potential to combat drug-resistant mutations at the orthosteric sites. Pyrazolo[1,5-a]-pyrimidine, a bioisostere of purine, is an important heterocyclic privileged scaffold in drug development. In recent years, pyrazolo[1,5-a]pyrimidine has been widely explored as a core skeleton in developing antitumor, anti-infective, anti-inflammatory, and central nervous system agents. This review summarizes the latest application of pyrazolo[1,5-a]pyrimidine as a privileged scaffold in allosteric modulators and its structure-activity relationship, aiming to provide a reference and basis for screening and optimization of allosteric modulators.
The transition metal complexes-catalyzed the asymmetric hydrogenation of unsaturated compounds is one of the most economical and efficient ways to obtain chiral compounds. After decades of efficient research on asymmetric catalysis, with transition metal catalytic asymmetric hydrogenation as the core technology, many chiral compounds, such as chiral amino acids, chiral alcohols, chiral amines, and chiral carboxylic acids, have been successfully prepared on industrials scale. This paper mainly provides an overview of methods for the industrial-scale asymmetric catalytic hydrogenation reduction of unsaturated compounds containing carbon-oxygen double bond(C=O), carbon-carbon double bond(C=C) and carbon-nitrogen double bond(C=N) in order to build the corresponding chiral drugs or active key intermediates.
IgG-like bispecific antibodies are artificially constructed functional antibodies with complicated production processes and by-products. It is not easy to develop a generic platform process like monoclonal antibodies and needs to develop specific purification processes. Mismatching products and aggregates are typical by-products in IgG-like bispecific antibody production, which have been a nodus of purification. This review briefly overviews the structures of IgG-like bispecific antibody molecules and their corresponding purification processes, and focuses on the removal strategies of asymmetric IgG-like bispecific antibodies homodimers, 1/2 half antibody or 3/4 antibody fragments lacking light chain, and aggregates of symmetric IgG-like bispecific antibodies, in order to provide some references and new ideas for the development of purification processes for IgG-like bispecific antibodies.
Pullulan(1), a natural polymer, has been increasingly widely used in the pharmaceutical and food industries because of its solubility, malleability, spinnability, edibility, biodegradability, non-toxicity, and well biocompatibility. It can be used as the film-forming material to prepare films, as the capsule shell material to prepare capsules, as the biodegradable material to prepare microneedles and injections, and as the carrier material for targeted drug delivery. This paper introduces the characteristics of 1, briefly reviews its current status in application in pharmaceutical preparations, and offers a prospect of 1 development.
This paper described a new method for preparing BAY2402234, a dihydroorotate dehydrogenase inhibitor. Benzyloxy ethyl acetate was converted into 5-[(benzyloxy)methyl]-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one(3) by hydrazinolysis, nucleophilic addition with ethyl isocyanate, and then ring-closes under alkaline conditions. The intermediate 3 underwent the two-step nucleophilic substitution, and the benzyl was removed by boron trichloride, then the key intermediate 4-[4-ethyl-5-oxo-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-[[(S)-1,1,1-trifluoropropan-2-yl]oxy]benzonitrile(7) was obtained by hydroxyacetalization. Compound 7 underwent the amide condensation with 2-chloro-6-fluoroaniline after alkaline hydrolysis, followed by the de-protection to obtain the target product, with a purity of 99.71% and a total yield of 17.34% based on benzyloxy ethyl acetate. At the same time, the chiral control method of BAY2402234 and its enantiomers was established. The ee value of the final product synthesized by the new method was more than 99.9%.
A novel synthetic process of riluzole(1) was reported in this paper. 1-[2-Mercapto-4-(trifluoromethoxy)phenyl]thiourea(4) was prepared through the condensation of 2-amino-5-(trifluoromethoxy)benzenethiol(2) and thiourea(3) in the presence of hydrochloric acid. Then, 4 was transformed into the target compound through intramolecular cyclization catalyzed by CuSO4·5H2O/TEA system with an overall yield of 79.3%(based on 2) and a purity of 99.9%. This synthetic method with stable process and simple operation has not yet been reported in previous literature.
(R)-9-[2-(Hydroxy)propyl]adenine(3) was obtained by condensation of adenine (2) with (R)-propylene carbonate. The substitution reaction of 3 with diethyl p-tosyloxymethylphosphonate was carried out in the presence of magnesium tert-butoxide, followed by the hydrolysis with bromotrimethylsilane to obtain (R)-9-[2-(phosphonomethoxy)propyl]adenine(4). The latter was esterified with trimethylamine, triphenyl phosphite and 4-dimethylaminopyridine to obtain (R)-9-[2-(phenoxylphosphonomethoxy)propyl]adenine(5). The chlorination of 5 by thionyl chloride in toluene followed by the substitution with L-alanine isopropyl ester produced propan-2-yl-N-[(S)-[[[(2R)-1-(6-amino-9H-purin-9-yl)prop-2-yl]oxy]methyl](phenoxy)phosphono]-1-alanine ester(6, namely tenofovir alafenamide). Tenofovir alafenamide fumarate(1) was prepared from 6 with 0.5 molar ratio of fumaric acid through seeded crystallization at 40 - 50 ℃. Both the chemical purity and the chiral purity reached to 99.99%, and the total yield was 24%(based upon 2).
In the quality study of paliperidone palmitate, eight related substances were prepared. These substances were 4-(6-fluorobenzo[d]isoxazol-3-yl)-1-[2-[2-methyl-4-oxo-9-(palmitoyloxy)-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl]ethyl]piperidine-1-oxide(1-1), 3-[2-[4-(2,4-difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl palmitate(1-3), and dodecane, tridecane, tetradecane, pentadecane, heptadecane and octadecane esters of paliperidone(1-5, 1-6, 1-7, 1-8, 1-9 and 1-10). Their structures were confirmed by MS and 1H NMR.
An atmospheric and room temperature plasma(ARTP) mutagenesis system was used to mutate the Bacillus subtilis SF90-5, whose main product was surfactins, into mutant strains mainly producing bacillomycin D(1). Matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry(MALDI-TOF-MS) and ultra performance liquid chromatography(UPLC) were used to analyze 1. The mutant strain, B. subtilis BMD-1, improved the yield of 1 from 0.55 g/L to 1.51 g/L, increasing by 175%. Scanning electron microscopy(SEM) and transmission electron microscopy(TEM) were used to observe the inhibition effect of 1 with different concentrations on the hyphae and spores of Aspergillus flavus. The results showed that 1 would affect the hyphal growth of A. flavus at 3 mg/L and cause damage to structures of hyphae and spores of A. flavus at 12 mg/L. In this study, a genetically stable mutant strain B. subtilis BMD-1 mainly producing 1 was obtained, providing a theoretical reference for studying the A. flavus inhibition of 1 and its production application.
The particle size and in vitro release are key quality attributes of long-acting injectable suspension. The values of d(0.1), d(0.5) and d(0.9) of paliperidone palmitate injection(Invega Trinza®, the Reference Listed Drug) were determined as 2 - 3、6 - 8 and 16 - 19 μm, respectively. So, the quality control standard of particle size distribution of the self-made long-acting injection was confirmed. Paliperidone palmitate injection was prepared by wet milling method. And the values of d(0.1), d(0.5) and d(0.9) of the self-made long-acting injection were (2.43±0.14),(6.74±0.29) and (17.34±0.90)μm, respectively. The in vitro release test was carried out with 0.001 mol/L hydrochloric acid containing 0.489% of Tween-20 as the release medium. The cumulative release rates at 5 min, 2 h, 6 h and 23 h of the self-made long-acting injection were (5.25±0.73)%, (47.30±1.17)%, (70.84±0.74)% and (91.24±0.55)%, respectively. According to the calculated results of similarity factor, the release curves between the self-made and reference preparations were similar. The in vitro characterization results showed that the morphology and crystal form of the self-made and the reference preparations were the same. In vivo pharmacokinetic study in rats showed that there were no significant differences in t1/2, tmax, cmax, AUC and MRT between self-made and reference preparations.
Firstly, the formulation and process of curcumin nanoemulsion were optimized by single factor test and Box-Behnken design combined with response surface methodology with encapsulation efficiency as evaluation index, and the physicochemical properties of curcumin nanoemulsion prepared under the optimal conditions were investigated. The results showed that the encapsulation efficiency of curcumin nanoemulsion was (95.69±0.04)%, and the particle size was (109.7±0.5)nm. Transmission electron microscopy showed that curcumin nanoemulsion was homogeneous spherical. Then the optimal curcumin nanoemulsion was added to the composite matrix gel composed of poloxamer 188 and poloxamer 407 to prepare a transdermal thermosensitive hydrogel, and its quality was evaluated and its transdermal performance was studied. The results showed that the hydrogel had good temperature sensitivity, the gelation temperature and time were (34.3±0.3)℃ and (54.2±10.2)s, respectively. The cumulative penetration amount Q24 h of the hydrogel was(9.93±0.70)µg/cm2 and the steady transdermal rate Js was 0.71 µg·cm–2·h–1, which were 2.5 times and 2.6 times of those of the curcumin solution, respectively. Finally, 2,4-dinitrochlorobenzene was used to establish a mouse model of chronic eczema, and the efficacy of the title product was investigated with the commercial compound dexamethasone acetate cream as a positive control. The results showed that compared with the model group, the title product could significantly reduce the ear mass difference and swelling degree of mice(P<0.05), and there was no significant difference in efficacy between the positive control(compound dexamethasone acetate cream) group and the product(P>0.05). In addition, the efficacy of this product was significantly different from that of the curcumin solution(P<0.05).
A series of fatty acid monoterpene alcohol ester derivatives were synthesized via chlorination reaction of monoterpene alcohols[α-terpineol(TER), L-menthol(MEN), geraniol(GER) and citronellol(CIT)], as lead compounds, and fatty acids[heptanoic acid(C7), myristic acid(C14), stearic acid(C18) and oleic acid(dC18)]. The in vitro permeation experiments were conducted with horizontal double chamber diffusion cell and excised rabbit skin as a skin barrier. The effects of the monoterpene alcohols and their monoterpene alcohol ester derivatives on in vitro permeation behavior of theophylline(1) in the isopropyl myristate(IPM) solutions was investigated. Compared with the blank group(without any permeation promoter), α-terpinol heptanoate(TER-C7), L-menthol heptanoate(MEN-C7), geraniol oleate(GER-dC18) and citronellol oleate(CIT-dC18) showed significant permeation promoting effects on 1(P<0.05). Among the cyclic monoterpene esters explored, MEN-C7 showed the best permeation promoting effect on 1. While among the tested chain monoterpene esters, GER-dC18 showed the best permeation promoting effect on 1. The cumulative permeation amount of 1 at 8 h of above two groups were 3.02 and 1.86 times higher than that of the blank group, respectively. Both cyclic and chain monoterpene alcohol ester derivatives showed significant permeation promoting effects on 1. Among which the cyclic monoterpene alcohol ester, MEN-C7, had the superior permeation promoting effect and was promised practical use in future transdermal application.
This study aimed to investigate the effects of solvent removal rate during the solidification process on the properties of microspheres, especially drug release rate. The leuprolide acetate(1)-loaded poly(lactic-co-glycolic acid)(PLGA) microspheres were prepared by a double emulsion-solvent evaporation method. The effects of solvent removal rate on the properties of microspheres were investigated with encapsulation efficiency, particle size, morphology, and in vitro drug release as the evaluation indexes. Different solvent removal rates were obtained by changing the process parameters, namely oil-water phase volume ratio(referred as volume ratio of internal water and oil phases to external water phase), solidification temperature, and mannitol concentration in the external water phase. The results indicated that the high oil-water phase volume ratio resulted in a slower solvent removal rate and lower drug encapsulation efficiency(from 74.7% decreased to 21.9%), making the aqueous-phase microdroplets within the emulsion droplets more prone to coalesce and creating larger pores on the surface and inside of the microspheres, thus accelerating the initial burst release. As the solidification temperature increased, the solvent removal rate was faster. However, there was no significant effect on the morphology of the microspheres, and the drug release rate was slightly accelerated. Due to the osmotic pressure, the solvent removal rate decreased after adding mannitol to the external water phase, making the microspheres with mannitol had a smooth and dense structure. But the drug would concentrate on the surface of the microspheres, which would increase the drug release rate. The variation in the solvent removal rate due to different process parameters during the solidification of the microspheres has a variable effect on the properties of the microspheres. The results provide a basis for establishing the correlation between process parameters and microsphere drug release behavior.
The aim of this study was to investigate the activity of (–)-terpinen-4-ol (1) against human respiratory syncytial virus(hRSV) infection in vivo. Firstly, 1 and ribavirin were respectively incubated with the hRSV high-virulence strain GZ08-18. Then, the obtained strains were used to infect mice as the treatment group and positive control group. The virus control group without any treatment was set up at the same time also. Assays for evaluation of mouse body weight, survival rate, virus titers of lung tissue homogenates, pathological sections of lung tissues, immunofluorescence intensity, and detecting the expressions of macrophage inflammatory protein(MIP-1α), interleukin(IL)-1α, IL-1β, IL-6, and tumor necrosis factor-α(TNF-α) in lung homogenates were conducted to check the anti-inflammatory effect of 1. The results showed that, compared to the virus control group, all treatment groups showed better weight recovery, survival rates, and lower lung homogenate viral titers. HE staining results of pathological sections showed the alveolar structure of the mice in the treatment groups and the positive control group were maintained, the alveolar septum was not thickened, and no fusion was observed. Immunofluorescence results showed that the expressions of viral protein in lung tissues significantly decreased in the treatment groups. The expressions of inflammatory cytokines in lung homogenates were downregulated, especially the decoding of MIP-1α and IL-1α decreased remarkably. This study reported a significant effect of 1 against hRSV infection in vivo for the first time.